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Visual pigmentRhodopsin is a classical two-state G protein-coupled receptor (GPCR). In the dark, its 11-cis retinal chromophore
serves as an inverse agonist to lock the receptor in an inactive state. Retinal–protein and protein–protein inter-
actions have evolved to reduce the basal activity of the receptor in order to achieve low dark noise in the visual
system. In contrast, absorption of light triggers rapid isomerization of the retinal, which drives the conversion of
the receptor to a fully active conformation. Several speciﬁc protein–protein interactions have evolved that
maintain the lifetime of the active state in order to increase the sensitivity of this receptor for dim-light vision
in vertebrates. In this article, we review the molecular interactions that stabilize rhodopsin in the dark-state
and describe the use of solid-state NMR spectroscopy for probing the structural changes that occur upon light-
activation. Amino acid conservation provides a guide for those interactions that are common in the class A
GPCRs as well as those that are unique to the visual system. This article is part of a Special Issue entitled: Retinal
Proteins — You can teach an old dog new tricks.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
1.1. Rhodopsin as a model class A GPCR
The class A receptors are the largest of ﬁve distinct classes of G
protein-coupled receptors (GPCRs). These receptors have a common 7
transmembrane (TM) helix architecture and catalyze the exchange of
GTP for GDP in intracellular heterotrimeric G proteins when activated.
One of the intriguing questions surrounding GPCRs is how the 7-TM
helix structure has evolved to be capable of responding to a diversity
of signals. Rhodopsin, the low-light receptor in vertebrates, has often
been considered an exception within the class A GPCRs, but is now
providing the basis for a common mechanism for activation.
Rhodopsin serves as a model GPCR. The receptor functions as an
on-off switch where light energy is used to drive the protein from an
inactive to an active conformation. All visual receptors from humans
to squid contain the 11-cis isomer of retinal covalently bound within
the 7-TM helix bundle (Fig. 1). In pharmacological terms, the 11-cis
retinal chromophore acts as a potent inverse agonist when bound to
the receptor and reduces basal activity of the apo-protein opsin to
very low levels [1,2]. Speciﬁc molecular interactions, including thoseroteins — You can teach an old
Smith).
ights reserved.involving 11-cis retinal, have evolved to lock this light-activated recep-
tor into an inactive conformation in the dark, allowing the reduction of
thermal “noise”. Upon light absorption, the retinal isomerizes within
200 fs [3], and then decays thermally through a series of spectrally
distinct intermediates. The Metarhodopsin II (Meta II) intermediate
corresponds to the active state of the receptor. Like rhodopsin, Meta II
is stabilized by speciﬁc contacts that enable sufﬁcient time for G protein
activation. Differences in these helix–helix interactions are what distin-
guish the highly sensitive rhodopsin receptors that function in dim-light
from the cone pigments that operate in ambient light conditions and
require faster response and recovery times [4].
In the transition from Meta I to Meta II, the receptor undergoes a
large conformational change. EPR studies revealed that there is an out-
ward rotation of the cytoplasmic end of TM helix H6 in the transition to
Meta II [5]. The motion of H6 opens up a cavity on the intracellular side
of the receptor that serves as the G-protein binding pocket. The crystal
structures of active opsin [6,7] showed that the outward rotation of
H6 is accompanied by rotation of the intracellular portions of TMhelices
H5 and H7. Speciﬁc contacts between conserved tyrosines on these he-
liceswith Arg135 on helix H3 serve to stabilizeH6 in an open conforma-
tion. Themechanism for how retinal isomerization is coupled tomotion
of helices H5, H6 and H7, however, is only now being unraveled.
1.2. NMR provides a complementary approach to X-ray crystallography
Rhodopsin was the ﬁrst GPCR whose crystal structure was deter-
mined at high resolution [8]. The structure conﬁrmed the seven-helix
Fig. 1. Packing interactions of the retinal chromophore in rhodopsin. (a) Structures of the 11-cis retinal chromophore in rhodopsin and the all-trans retinal chromophore in the active in-
termediate,Meta II. (b, c) Two views of the structure of the retinal-binding pocket in rhodopsin (PDB ID: 1GZM). The view from the extracellular surface (b) shows several of themolecular
interactions that lock the receptor in the inactive conformation in the dark. These include the Glu113–retinal PSB electrostatic interaction, the Glu122\His211 hydrogen bonding inter-
action and the close van derWaals packing interaction between Trp265 and the retinal polyene chain. The viewof the binding site from themembrane clearly shows howTrp265 is tightly
packed between the retinal, Ala295 and Gly121. Ala295 is group-conserved across the class A GPCRs, while Gly121 is highly conserved within the opsin subfamily of receptors. The indole
side chain of Trp265 is hydrogen bonded to Asn302 via water molecules (dotted spheres).
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conserved across the large class A GPCR family. In the past 8 years a
number of high-resolution crystal structures of class A GPCRs have
been determined, mainly in their inactive forms. In addition to the
visual pigments [6,7,9,10], high-resolution structures have been deter-
mined for amine [11–21], chemokine [22], mAChR [23,24], opioid
[25–28], lipid [29] and δ-subfamilies of receptors [30], the latter includ-
ing the olfactory receptors. The basic structural elements present in
these structures are similar to those observed in rhodopsin. Comparison
of rhodopsin with the ligand activated GPCRs shows that the largest
structural diversity occurs in the N-terminus, the extracellular loops
and the intracellular loops. On the extracellular side of rhodopsin, the
second extracellular loop (EL2) is wedged between the TM helices and
serves as a cap on the retinal-binding site. On the intracellular side, a
short amphipathic helix is oriented roughly perpendicular to the
seven TM helices.
In contrast, crystal structures of active GPCRs are fewer in number.
Active state crystal structures of ligand-activated receptors that exhibit
a large outward motion of H6 have been determined for the β2-
adrenergic receptor with either a nanobody or the full length G protein
bound to the intracellular surface [31,32]. In the presence of agonist
alone, the structural changes in the ligand-activated GPCRs are more
modest [15,33]. These receptors have relatively small barriers to activa-
tion in contrast to rhodopsin where light energy is needed to overcome
the large thermal barrier to activation. Inmost GPCRs, multiple receptor
conformations can be populated, which provides versatility in signaling
and regulation [34].
Agonist-bound structures are available for the A2A adenosine recep-
tor [15,35], the β1 adrenergic receptor (β1AR) [33,36], the β2 adrenergic
receptor (β2AR) [37] and the β2AR in complex with Gs [32,38]. The
largest change in these structures, as compared to the corresponding
inactive conformation, is the displacement of TM helix H6. Agonist-
induced conformational changes in other regions of these receptors
appear to beminimal, which has left open the question as to how ligand
binding triggers activation [39,40].
In order to correlate structure with function in GPCRs, a detailed
understanding of the subtle differences between the various receptor
conformations is required. High-resolution structural data are needed
for each receptor state in as close to a native conformation as possible.
Solid-state NMR spectroscopy has been particularly useful in character-
izing the structure of dark rhodopsin and its intermediates. Deuterium
NMR spectroscopy along with molecular dynamics has provided in-
sights into the structure and dynamics of the retinal chromophore
[41], while 13C and 1H NMR correlation spectroscopy has been used toprobe the retinal structure and its interaction with surrounding amino
acids [42,43] The use of selective pairs of 13C labels has been useful for
characterizing the conformation of the retinal [44] and internuclear
13C…13C distances in the protein [45]. The receptor structure can be
probed in a membrane environment using the native protein sequence
or site directed mutants, and low temperature [46] provides a way to
trap intermediates. In this review, we describe the use of solid-state
NMR in the context of understanding the molecular interactions that
stabilize the active and inactive states of rhodopsin. We highlight the
retinal chromophore and its interactions with His211 on H5 and
Trp265 on H6 to illustrate the types of structural information that can
be obtained by NMR.1.3. Molecular interactions and residue conservation provide insights into
mechanism
Understanding the roles of the residues that are conserved across
the class A GPCR family is an important component for developing a
comprehensive description of the activation mechanism of rhodopsin.
There are three levels of conservation that one must consider. The ﬁrst
level of conservation corresponds to the ~20 signature residues that
have high sequence identity across the class A GPCRs. These residues
are often grouped into structural and functionalmicro-domains that ap-
pear to mediate a common conformational switch involved in receptor
activation. A second level of conservation corresponds to those residues
that are highly conserved when considered as a group of similar amino
acids. We have previously identiﬁed the group of small and weakly
polar residues (Ala, Gly, Ser, Cys and Thr) as key determinants in
helix–helix interactions [47,48]. However, there are other classiﬁcations
of group-conserved amino acids, such as aromatic, charged or hydro-
phobic. The third level of conservation corresponds to those residues
that are highly conserved within a receptor subfamily.
For example, in rhodopsin an aromatic cluster of amino acids is
found on H6, which has relatively high sequence identity across the
class A GPCRs. Trp265 lies within the arc formed by the retinal polyene
chain and the Lys296 side-chain, and is packed between Gly121 and
Ala295 (Fig. 1). Gly121 and Lys296 are highly conserved in the visual
receptor subfamily and Ala295 is a group-conserved residue across the
class A GPCRs. The 11-cis retinal appears to function as a clamp to
prevent motion of Trp265 and H6 [49], thus locking the dark-state
conformation. Isomerization of the retinal and motion of the β-ionone
ring towardH5 appear to be essential formotion of Trp265 [49]. Togeth-
er, the conserved amino acids form a network spanning all seven
685A. Pope et al. / Biochimica et Biophysica Acta 1837 (2014) 683–693transmembrane helices and mediate the conformational switch(es)
that governs activation of the class A GPCRs.
2. Packing interactions involving the retinal chromophore
2.1. Retinal isomerization triggers receptor activation
The 11-cis retinal ligand is attached to Lys296 through a protonated
Schiff base (PSB) linkage. The positive charge created by protonation of
the Schiff base increases electron delocalization along the conjugated
retinylidene chain and shifts the absorption band from the short wave-
length range into the middle of the visible spectrum. The protein coun-
terion to the positive charge is Glu113 on helix H3. The Glu113–PSB salt
bridge is crucial not only for wavelength regulation, but also for main-
taining the receptor in an inactive conformation. Proton transfer from
the PSB to Glu113 is an essential element in triggering receptor activa-
tion [50] and is explained further in Section 5.
The 11-cis retinal chromophore is longitudinally restrictedwithin its
binding pocket. The shape of this binding pocket imparts a twist about
the C11\C12 double bond of the 11-cis retinal that guides the cis to
trans isomerization within this constrained binding site. Deuterium
measurements on the retinal reveal that the C20 methyl group is
displaced out of the retinal plane and provided evidence for the ‘pre-
twist’ about the C11\C12 double bond [51,52]. This conformational
distortion “primes” the retinal for isomerization [53–55].
NMR measurements of dipolar interactions between 13C sites along
the retinal provide support for conformational distortions in its ground
state structure. Such measurements yield a value of 160° ± 10° for the
H\C10\C11\H torsion angle in rhodopsin [56] and 180° ± 25° in theFig. 2. Solid-state NMR spectroscopy of rhodopsin and Meta II illustrating changes in retinal–T
internuclear contacts. This region of the spectrum corresponds to cross peaks within the Trp
for the experiment in panel (b), the retinal was 13C labeled at both C12 and C20. The close 13C
and Meta II (red, ~138 ppm). The contour plot in (b) was scaled to observe the weak C20\Tr
from the 2D spectra shown in panels (a) and (b). The rows clearly show the intensity differenMeta I intermediate [57] indicating that this region of the retinal has re-
laxed following isomerization. A twist about the C10\C11 bond in the
ground state is consistent with data from rotational resonance experi-
ments measuring the distance between the C20 methyl group and the
polyene chain in rhodopsin and in the Meta I intermediate [58]. Double
quantum ﬁltering (DQF) methods greatly enhance the signal arising
from enriched directly bonded 13C pairs relative to the natural abun-
dance 13C signals and have provided an avenue for studies of retinal
conformation.
Both the retinal polyene chain and its associated methyl groups
contribute to the ability of the retinal to trigger activation. Steric interac-
tions involving the retinal C19 and C20 methyl groups inﬂuence activa-
tion. The C20methyl group in rhodopsin contacts Trp265 and Tyr268 on
H6 in the dark state.When the retinal C20methyl group is removed, the
photoreaction is slowed [59] and the quantum yield is reduced [60]. The
retinal C19 methyl group in rhodopsin is tightly constrained in the
retinal binding site and packs against Thr118, Ile189, Tyr191 and
Tyr268. Removal of the C19 methyl group prevents receptor activation
[61], while replacement of the retinal C19 methyl group with an ethyl
or propyl group converts the 11-cis PSB chromophore from a potent in-
verse agonist into a partial agonist, with the amount of activity being
proportional to the size of the substituent at the C19 position [62].
Fig. 2 presents two-dimensional solid-state NMR spectra illustrating
the contacts between the retinal C19 and C20 methyl groups and
Trp265 in rhodopsin and Meta II. The experiments were run with the
retinal 13C-labeled at the C19 or C20 methyl groups and 13C-labels on
tryptophan residues in the protein. The 13C-labeled tryptophan was
introduced by expressing rhodopsin using deﬁnedmedia containing se-
lectively labeled amino acids [63]. The 13C-labeled retinal wasrp265 contacts. (a, b) Regions of the two-dimensional DARR NMR spectra used to obtain
side chain and between Trp265 and the retinal C19 and C20 methyl groups. In addition,
12…13C20 distance (~2.5 Å) results in large cross peaks for rhodopsin (black, ~132 ppm)
p265 cross peak, resulting in an increase in noise. (c, d) One-dimensional rows extracted
ces, which are used to estimate internuclear distance.
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containing speciﬁc 13C-labels. This labeling strategy introduces sparse
13C sites throughout the protein, allowing us to measure 13C…13C
distances via themeasurement of 13C…13C dipolar couplings. Structural
constraints in NMR spectroscopy are often in the form of internuclear
distance. Magic angle spinning (MAS), which is used to obtain high
resolution NMR spectra of membrane proteins by solid-state NMR,
averages dipolar couplings with magnitudes on the order of or less
than the MAS frequency. Selective reintroduction of dipolar couplings,
while retaining the high resolution ofMAS, allows internuclear distance
measurements using the 1/r3 distance dependence of the dipolar inter-
action. Several methods have been developed to reintroduce dipolar
couplings under MAS conditions in order to measure distances
[64–70]. However, we have found dipolar assisted rotational resonance
(DARR) NMR, which is based on spin diffusion, to be the most effective
method to obtain distances in 13C-labeled membrane proteins [71].
DARR allows polarization transfer in a manner that is relatively insensi-
tive to the chemical shift differences [70]. Typically, the 2D 13C DARR
spectrum is shown as a contour plot with diagonal resonances and off
diagonal cross peaks. The off-diagonal cross peaks arise from 13C sites
that separated in space by less than ~6–7 Å. The intensity of the cross
peaks is inversely related to internuclear distance. For simplicity, we
often only show rows through the cross peaks, which allows one to
estimate their relative intensities.
In Fig. 2, we present both 2D contour plots and rows through the 2D
spectra in the region of the retinal–Trp cross peaks. The spectra of rho-
dopsin (black) and Meta II (red) are superimposed. The large reso-
nances in the 2D spectra correspond to intra-residue cross peaks
between the Cβ carbons of the 5 tryptophan residues and the aromatic
carbons of the indole ring. The smaller resonances (blue box) corre-
spond to the speciﬁc cross peaks between the retinal C19 or C20methyl
carbons and Trp265. There are two features of these spectra that emerge
from a comparison of the C19 and C20 cross peak intensities. First, the
C20–Trp intensity is weak, indicating a relatively long intermolecular
distance. In an independent study, de Groot and colleagues observed a
correlation between C8 and Trp265 in rhodopsin, but were not able to
observe the edge-on contact with the C20 methyl group even though
the distances (~3.9 Å) are comparable [42]. Second, in the contour
plots it is clear that the C20methyl group is coupled to only a single car-
bon of the aromatic ring. In contrast, the C19methyl group is coupled to
several aromatic carbons. This comparison indicates that the C20meth-
yl group is oriented toward the edge or end of the indole ring (consis-
tent with the crystal structure of dark rhodopsin), whereas the C19
methyl group is in van der Waals contact (or very closely packed) to
the surface of the indole ring (i.e., the intensity of the inter-residue
C19–Trp cross peak approaches that of the intra-residue Trp cross
peaks).
2.2. Orientation of the retinal chromophore in Meta II
In the past few years, several crystal structures have been reported
on the active Meta II state of rhodopsin [9,72,73]. Two structures have
been reported on rhodopsin containing mutations (E113Q and
M257Y) that lead to constitutive activation [50,51]. These structures
were obtained with the all-trans retinal chromophore present in the
retinal-binding site. In the E113Q structure, the all-trans retinal was
not covalently attached. In the M257Y structure, the all-trans retinal
was attached as an unprotonated Schiff base to Lys296. In the third
Meta II structure, all-trans retinal was added to crystals of opsin to gen-
erate a Meta II-like complex. In this opsin–retinal complex and the
M257Y structure, the orientation of the retinal is different than the ori-
entation proposed on the basis of solid-state NMR measurements.
An analysis of the cross-peak intensities in Fig. 2 provides a point of
comparison between the crystal structures andMeta II studied by NMR.
The intensity of the retinal–C20 cross peak is consistent with the crystal
structure of rhodopsin showing that the C20 methyl group is orientededge-on to the Trp side chain. The closest carbon (Cζ3) is 3.9 Å away.
The relatively weak intensity is due to dipolar truncation (which occurs
when measuring a weak through-space interaction in the presence of a
strongly coupled system, in this case the uniformly 13C-labeled trypto-
phan) [74]. Comparison with crystal structures of Meta II shows that
the C19 methyl group is still oriented approximately edge-on to the
Trp265 indole side chain. The C19\Trp distance is longer in the
structure of “wild-type”Meta II (3PQR) than in rhodopsin [9], which is
inconsistent with the measured intensities. The distance is closer in
the structure of the M257Y mutant of Meta II [73]. However, the orien-
tation still results in only 1 or 2 carbons being relatively close to the
Trp265 indole ring.
Meta II involves at least two substates, referred to as Meta IIa and
Meta IIbH+ [75]. The ﬁrst corresponds to the outward rotation of H6
and the second protonation of Glu134 in the conserved ERY sequence
on H3. Once Arg135 is stabilized by the inward rotation of Tyr223 and
Tyr306, the retinal is hydrolyzed and can leave the binding pocket. In
the solid-state NMR experiments, we trapMeta II following protonation
of Glu134 (substate Meta IIbH+), but prior to Schiff base hydrolysis.
The retinal chemical shifts at the opposite ends of the polyene chain
(C5 and C15) are unusual [76]. For example, the retinal C5 chemical
shift is upﬁeld compared to that in model retinal Schiff bases. The
upﬁeld chemical shift suggests that the C5C6C7C8 torsion angle
(which connects the β-ionone ring to the retinal polyene chain) is
appreciably non-planar Meta II. The non-planar angle would be consis-
tent with steric interactions between the ring and residues on TM helix
H5. In addition, 1H and 13CMASNMR have provided evidence for strong
steric interactions between β-ionone ring of the retinal chromophore
and surrounding aromatic residues [43]. We have suggested that relax-
ation of the retinal and surrounding protein occurs upon retinal hydro-
lysis [76]. This relaxed state associated with opsin may be more
amenable to X-ray crystallography.
2.3. Packing and position of Trp265 in rhodopsin and Meta II
The orientation of the retinal has implications on the position of the
Trp265 side chain in Meta II. In the static crystal structures of Meta II
[9,72,73] and of activated GPCRs [15,32,36–38], the conserved Trp
residue has not shifted signiﬁcantly from its position in the inactive
state. These data suggest that the tryptophan serves as an anchor
point on the helix. In contrast, there are several studies, using experi-
mental systems that do not require crystallization, which have argued
for larger changes in the position of the tryptophan upon activation.
Chabre and Breton [77] used linear dichroism to show that at least
one of the ﬁve tryptophans changes orientation upon retinal isomeriza-
tion. Rafferty and coworkers [78] interpreted UV–Vis difference bands
that appear in the formation of Meta II as resulting from two trypto-
phans moving into more polar environments. Lin and Sakmar were
able to assign the peaks observed in the UV–Vis difference spectra to
speciﬁc tryptophans by combining optical spectroscopy with site-
directed mutagenesis [79]. They found that the difference bands at
294 nm and 302 nm are associated with changes in the environments
of Trp126 and Trp265. Importantly, Trp35 and Trp175 do not contribute
to the difference spectra, while Trp161 contributes only slightly. Based
on comparison to model compounds, they attributed the absorption
changes to decreased hydrophobicity or polarizability in Meta II, and
weaker hydrogen bonding interactions of the indole NH groups. These
conclusions parallel those using UV Raman spectroscopy [80].
Fig. 3a shows the hydrogen bonding interactions of Trp265 with
structural waters (dotted van der Waals spheres) surrounding Asn302.
Solid-state NMR of 15N\Trp-labeled rhodopsin provides a more direct
assessment of the hydrogen bonding of the indole N\H groups [81].
Fig. 3b presents the 15N MAS spectrum for wild-type rhodopsin
(black) containing tryptophan uniformly labeled with 13C and 15N.
Both the backbone amide and sidechain indole of the ﬁve Trp residues
are 15N-labeled. The 15N spectrum of rhodopsin shows ﬁve distinct
Fig. 3.Hydrogen bonding changes of tryptophan indole NH groups. (a) Structuralwaters located between the indole NH of Trp265 and the side chain amide of Asn302mediate hydrogen-
bonding interactions between these two highly conserved residues. (b) 15N NMR spectra are shown corresponding to the indole NH resonances of tryptophan in rhodopsin (black) and
Meta II (red). The Trp126 resonance at 130 ppm shifts to 128 ppm, while the Trp265 resonance shifts from 127 ppm to 123 ppm (marked with arrow).
Table 1
Amino acid conservation in class A GPCRs.
Signature conserved Packing values Group conserved Packing values
Asn551.50 99.5% 0.624 Gly511.46 92.5% 0.619
Leu792.50 94.0% 0.486 Ile541.49 77.7% 0.464
Ala802.51 97.4% 0.574 Ala822.53 82.2% 0.552
Asp832.54 89.4% 0.582 Ala1243.39 77.9% 0.472
Cys1103.25 89.2% 0.654 Ala1323.47 99.7% 0.528
Leu1283.43 77.6% 0.497 Ala1534.42 81.0% 0.529
Glu1343.49 71.7% 0.522 Ala1644.53 92.6% 0.610
Arg1353.50 98.1% 0.514 Ala1684.57 87.5% 0.668
Tyr1363.51 71.6% 0.467 Ala2957.42 83.4% 0.596
Trp1614.50 88.4% 0.411 Ala2997.42 78.0% 0.529
Cys187EL2 87.4% 0.676
Pro2155.42 72.8% 0.636
Tyr2235.50 93.2% 0.250
Pro2676.50 80.1% 0.351
Asn3027.49 85.7% 0.422
Pro3037.50 98.1% 0.500
Tyr3067.53 93.2% 0.585
Trp2656.48 69.2% 0.575
a. Conservation was calculated on the basis of themost recent alignments in the GPCR da-
tabase. b. The packing valueswere calculated using themethod of occluded surfaces. c. The
superscripts correspond to the generic numbering system developed by Ballesteros and
Weinstein (e.g., Trp2656.48) that gives the position of an amino acid relative to the most
conserved amino acid on a speciﬁc helix. In this example, the superscript 6.48 indicates
that Trp265 is two residues toward the N terminus of the most conserved residue (desig-
nated 50) on H6 (i.e., Pro2676.50).
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shifts, the three resolved resonances between 105 and 120 ppm are
assigned to backbone amide nitrogens and the two resolved resonances
between 125 and 133 ppm are assigned to indole nitrogens [82]. Inte-
gration of the intensity of each peak shows an approximate 2:1:1:1:1
ratio after subtracting the broad component. This intensity ratio sug-
gests that only three of the ﬁve tryptophans are resolved and that the
other two tryptophans contribute to the unresolved broad baseline
[81]. Mutational studies on the Trp residues allow us to assign Trp126
as the most downﬁeld shifted Trp consistent with strong hydrogen
bonding with Glu122 in rhodopsin ([81], unpublished data). Trp265 is
themost upﬁeld shifted Trp consistent with hydrogen bonding to struc-
tural water.
Fig. 3b also presents the 15N MAS spectrum of wild-type Meta II
(gray). Comparison of wild-type dark rhodopsin with Meta II reveals
changes mainly in the chemical shifts of the indole nitrogens. The 15N
resonances of the amide nitrogens are broadened slightly in Meta II,
but are at the same frequencies as in rhodopsin. In contrast, in the indole
region of the spectrum there is a loss of intensity at ~130 ppm and a
gain of intensity at 123 ppm and 127 ppm. Grifﬁn and coworkers [83]
have shown that the chemical shift of the indole nitrogen in tryptophan
model compounds and bacteriorhodopsin is correlated with hydrogen
bond strength. Decreased hydrogen-bonding results in a shift of the in-
dole 15N resonance to lower 15N frequency. Based on the observed shift
of two of the indole 15N resonances to lower 15N frequency in Fig. 3, we
conclude that at least two tryptophans in the TM region become more
weakly hydrogen bonded in Meta II. We have assigned these to
Trp126 and Trp265. Trp126 becomes more weakly hydrogen bonded
as the Glu122 side chain switches hydrogen-bonding interactions to
the side chain of His211 in Meta II. The hydrogen bonding changes of
Trp265 aremore difﬁcult to explain on the basis of the crystal structures
of Meta II, where the Trp265 side chain remains oriented in roughly the
same position as in rhodopsin.
3. Amino acid conservation and packing within the TM core
of rhodopsin
Most of the highly conserved residues in the class A GPCR family are
located in the TMhelices (Table 1). The “signature” amino acidswith se-
quence identities of N70% are the most important set of conserved res-
idues in the class A GPCR family. The conserved prolines on H5, H6 andH7, along with the (E/D)RY and NPxxY motifs, have been extensively
studied. Several hydrophobic residues (e.g., Trp161 and Leu79) are
highly conserved, but less well studied because it has not been clear
how they are involved in receptor structure or function. To understand
the role of the signature residues, it is important to consider helix pack-
ing and the positions of water, as well as their position relative to the
group-conserved residues described above.
Fig. 4 highlights the packing interactions of the seven TM helices in
rhodopsin and opsin. The helices are color-coded based on their overall
packing value determined by taking the average packing value of the in-
dividual amino acids in each helix. H3 has the highest packing value,
while H5 has the lowest overall packing value. We have previously sug-
gested that helices H1–H4 (and possibly H7) form a tightly packed core
on the basis of the location of the group-conserved positions [47,48].
Fig. 4.Helix packing in rhodopsin and active opsin. The seven TMhelices are color coded according to the average packing values of the residues in each helix for rhodopsin (PDB ID: 1U19)
and active opsin (PDB ID: 3CAP). Thepacking valueswere calculated using themethod of occluded surfaces [90]. For reference, the average packing value for residues in TMhelices is ~0.44
[48]. Red (N0.495), orange (0.494–0.475), orange-yellow (0.474–0.455), yellow (0.454–0.435), lime green (0.434–0.415), green (0.414–0.395), light blue (0.394–0.375), and blue
(b0.375).
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of rhodopsin illustrating the conserved packing core. The core is com-
posed of both signature (red) and group conserved (blue) amino
acids. The most highly conserved residue in the class A GPCRs is
Asn55. Close analysis of the amide functional group shows that the
amine NH2 is hydrogen bonded to the backbone carbonyls of Gly51 on
TM helix H1 and Ala299 on H7, both group conserved amino acids.
Asp83 is part of the highly conserved LAxAD sequence on TM helix
H2. Leu79 and Asp83 are signature residues, while Ala80 and Ala82
are group conserved. The very high group conservation of Ala80 (97%)
allows close H1–H2 packing and the formation of a speciﬁc Asn55\
Asp83 hydrogen bonding contact. Ala82 mediates the packing of helix
H2 with helices H3 (Ile123) and H4 (Trp161). Together, Ala82 and
Ile123 form a pocket that allows hydrogen bonding of Trp161 (indoleFig. 5. Packing within the transmembrane core of rhodopsin and the β2AR. Cross sections are
3PQR) (b), inactive β2AR (PDB ID: 2RH1) (c) and active β2AR (PDB ID: 3SN6). The signature r
has high conservation within the subfamily of visual receptors and Ile278 (green) has high conNH) to Asn78, thereby bridgingH2 andH4. Fig. 5b shows the conforma-
tional changes in the packing core upon activation. An analysis of the
hydrogen bonding interactions of Trp161 indicates that it does not
change upon activation, although the crystal structures of opsin and
Meta II show a change in conformation. The most dramatic change is a
closing of the space between Leu128 and Asn302 as H6 pivots outward,
displacing Met257.
For comparison, the packing core in the inactive and active confor-
mations of the β2AR is shown in Fig. 5c and d. These ﬁgures illustrate
how a crevice created by Ala78 on H2 and Ala119 on H3, both group
conserved residues, allows thedocking of Trp158. In this case, the indole
NH of Trp158 is hydrogen bonded to the side chain of Ser74. This com-
parison shows that a key polar residue precedes the LAxADmotif on H2
in both rhodopsin and the β2AR. As with rhodopsin, the most dramaticshown from the crystal structures of rhodopsin (PDB ID: 1U19) (a), active opsin (PDB ID:
esidues are highlighted in red and the group conserved residues in blue. Met257 (green)
servation within the subfamily of amine receptors.
Table 2
Interhelical hydrogen bonding interactions in rhodopsin and active opsina.
Interaction Distance (angstroms)
1GZM 3CAP
H1–H2
Asn55(δ-O)\Asp83(δ-O) 2.5 2.8
H1–H7
Tyr43(OH)\Phe293(CfO) 2.6 –
Asn55(δ-N)\Ala299(CfO) 2.9 2.9
H2–H3
Asn78(δ-N)\Ser127(OH) 3.5 2.9
H2–H4
Tyr74(OH)\Glu150(ε-O) 2.9 –
Asn78(δ-O)\Trp161(ε-N) 2.7 3.2
Asn78(δ-N)\Thr160(OH) 3.0 2.8
H2–H7
Asn73(δ-N)\Tyr306(OH) 3.2 –
H3–H5
Glu122(ε-O)\His211(δ-N) – 3.2
Glu122(ε-O)\His211(CfO) 2.8
Trp126(ε-N)\His211(δ-N) 3.3 3.3
Arg135(η-N)\Tyr223(OH) – 2.7
Tyr136(OH)\Gln225(ε-N) 3.0 –
H3–H6
Arg135(η-N)\Glu247(ε-O) 2.9 –
Arg135(η-N)\Glu247(CfO) 3.4 –
H3–H7
Glu113(ε-O)\Lys296(ζ-N) 3.2 –
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and Asn322 on H7 as Ile278 on H6 pivots away from the core. This
change is not as marked as in rhodopsin, but still reﬂects an important
ratcheting of H3 relative to H6 upon receptor activation.
The comparison between rhodopsin and theβ2AR highlights the im-
portant role thatMet257 plays in rhodopsin. In fact, one of the strongest
arguments that rhodopsin can serve as a model class A GPCR is that
mutation of Met257 allows activation of opsin by the addition of all-
trans retinal as a diffusible ligand [84]. That is, a single mutation in the
TM core can convert the receptor into a ligand-activated receptor.
Most substitutions of Met257 exhibit low, but measurable, activity
without bound retinal. These receptors are locked off by covalent at-
tachment of the “inverse agonist” 11-cis retinal, but exhibit activities
comparable to the light activated receptor upon binding the “agonist”
all-trans retinal. For example, the M257I mutation (where isoleucine is
the wild-type residue in β2AR) exhibits 4.4% opsin activity, 1.0% activity
with bound 11-cis retinal and 71% activity with the addition of all-trans
retinal. These results suggest that methionine at position 257
stabilizes the inactive state of rhodopsin, whereas isoleucine allows
H6 to easily rotate into an active orientation upon “ligand” binding.
More polar substitutions at position 257 in the M257Y, M257N, and
M257S mutants appear to stabilize a direct interaction with Arg135,
hold H6 in an active orientation and result in high levels of constitutive
activity.
Fig. 6 presents the packing interactions involving Trp265 in rhodopsin.
Trp265 is located between Gly121 on H3 and Ala295 on H6. Gly121 is
highly conserved in the visual receptor subfamily,while Ala295 is a highly
group conserved residue. Fig. 6b presents NMR spectra illustrating chang-
es in Trp265 packing interactions between rhodopsin and Meta II.H4–H5
Ala166(CfO)\Tyr206(OH) 2.6 2.9
H5–H6
Lys231(ζ-N)\Thr251(OH) – 2.8
Lys231(ζ-N)\Glu247(ε-O) – 3.0
Ala234(CfO)\Gln244(ε-N) – 3.4
a A cutoff of 3.5 Å between heteroatoms was used for inferring interhelical hydrogen
bonding interactions. In crystal structures, the protons within hydrogen bonds are not
directly observed.4. Hydrogen bonding interactions between TM helices
The packing interactions of the seven TM helices inﬂuence the
energy cost of moving helices relative to one another. Close helix–
helix contacts allow stabilizing hydrogen-bonding interactions to
form. In contrast, water can line the interfaces between more loosely
packed helices, which allow helix motion. Table 2 lists inter-helical
hydrogen-bonding interactions between the TM helices based on the
crystal structures of rhodopsin and active opsin. Two of these contacts
are highlighted in Fig. 7. The ﬁrst hydrogen-bonding network involves
the amide side chain of Asn55 (Fig. 7a). Asn55 is the most highly
conserved residue in the class A GPCRs. The orientation of the side
chain appears to be tightly controlled by the hydrogen bonding of the
amide NH2 protons to the backbone carbonyl oxygens of Gly51 and
Ala299, two group conserved residues.Fig. 6. Packing interactions involving Trp265 in rhodopsin. (a) Trp265 is located between Gly
changes in Trp265 packing interactions between rhodopsin and Meta II. Activation results in loA second example of inter-helical hydrogen bonding contacts in-
volves the interaction of the Glu122 carboxyl group on H3 with the
backbone carbonyl of His211 (Fig. 7c and d). The His211 carbonyl is
free to hydrogen bond due to the presence of proline at position 215.
Activation of the rhodopsin leads to a shift of the hydrogen bonding
contacts from the backbone CfO to the side chain imidazole in Meta II.121 on H3 and Ala295 on H6 in rhodopsin (PDB ID: 1GZM). (b) NMR spectra illustrating
ss of a cross peak between Gly121 on H3 and the indole ring of Trp265 on H6.
Fig. 7. Hydrogen bonding interactions between TM helices in rhodopsin. (a) Hydrogen bonding between the backbone carbonyl oxygens of Gly51 and Ala299 and the amide group of
Asn55 serves to orient the Asn55 side chain in rhodopsin (PDB ID: 1U19). (b) One-dimensional 13C spectra of rhodopsin (black) and Meta II (red) labeled with U-13C-labeled histidine.
Hydrogen bonding interactions between Glu122 and His211 are reﬂected by the changes in the CfO and Cδ2 chemical shifts. (c) Hydrogen bonding interactions between Glu122,
Trp126 and His211 in rhodopsin (PDB ID: 1U19). (d) Changes in hydrogen bonding between Glu122, Trp126 and His211 following activation in Meta II (PDB ID: 3PQR).
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to distinctive changes in 13C chemical shifts. Hydrogen bonding changes
lead changes in the electron density about associated 13C atoms, and
these in turn are reﬂected in changes in chemical shifts [85,86]. When
viewed from the extracellular surface of rhodopsin, the retinal β-
ionone ring is packed against Glu122. Retinal movement disrupts the
hydrogen bond between the main chain carbonyl of His211 and the
side-chain of Glu122, and a new hydrogen bond forms between
Glu122 and the imidazole δ-nitrogen of His211. A direct side-chain in-
teraction explains mutational data on His211 that point to a role of
the His211 side-chain in Meta II stability and activation [87]. Both
NMR measurements and X-ray crystal structures of active opsin and
Meta II indicate that the position of the ring has shifted toward helix
H5 in Meta II. The shift in the position of the retinal is likely a conse-
quence of isomerization to the longer all-trans conﬁguration as well as
the coupled motion of EL2 and H5. These observations are consistent
with studies using retinal analogs that show that the β-ionone ring is
required for rhodopsin activation [88,89].5. Electrostatic interactions within the TM region of rhodopsin
Charged residueswithin the interior ofmembrane proteins are often
functionally important. There are two key electrostatic interactions
within the TM region of rhodopsin. These interactions correspond tothe retinal PSB and its negatively charged counterion, and the electro-
static interaction connecting Arg135 to Glu134 and Glu247.
Fig. 8 presents the structure of rhodopsin showing the location of
Trp265 relative to the retinal chromophore, TM core and two proton-
ation switches responsible for rhodopsin activation. The conserved TM
core lies between the Glu113–PSB salt bridge on the extracellular side
of the receptor and the Arg135\Glu247 “ionic lock” on the cytoplasmic
side of the receptor. There is a growing body of evidence that these two
ionic pairs function as protonation switches that control rhodopsin acti-
vation [50]. Internal proton transfer occurs from the retinal PSB to
Glu113 upon activation, which allows H6 to pivot and rotate outward
on the intracellular side of rhodopsin. This motion of H6 breaks the
ionic lock on the intracellular side of the protein and allows the uptake
of a proton from the solvent by Glu134, thereby stabilizing the active
state. The sequence of events in the activation mechanism (i.e., proton-
ation of Glu113 by an internal proton transfer, an outward rotation of
H6 and protonation of Glu134) is associated with a series of Meta II
substates [75].
In many receptor subfamilies, the classic ionic lock between Arg135
and Glu247 is absent. For example, in the chemokine receptors the in-
tracellular end of H6 is highly positively charged and lacks a negatively
charged residue at or near position of this glutamate. Instead, there are
two highly subfamily conserved residues (Thr 97%; Asp 85%) at the
intracellular end of H2 that are positioned close to the arginine of the
E/DRY motif in homology models of the chemokine receptors. These
Fig. 8. Structure of rhodopsin. The conserved TM core lies between the two protonation switches (PS1 and PS2, blue boxes) required for receptor activation [50]. The ﬁrst protonation
switch involves a proton transfer from the retinal PSB toGlu113. The second protonation switch involves the protonation of Glu134 from the cytoplasm. It is thought that both protonation
switches are shielded from bulk water [91], which would increase the interaction energy between complementary charges. Rhodopsin structure is shown using PDB ID: IU19.
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tor conformation. Chemokine receptors also have low conservation
(52%) of the tyrosine in the NPxxYmotif on H7 consistent with a differ-
ent type of intracellular ionic lock. Nevertheless, conservation of the
transmembrane core and the conserved Tyr223 on H5 suggests that
the signaling pathway is not dramatically different from that described
for rhodopsin. These and other examples emphasize the interplay of the
signature, group-conserved and subfamily conserved amino acids in un-
derstanding the similarities and differences in how the class A GPCRs
are activated.Acknowledgements
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